Picture of Inotiv logo

NOTV Inotiv Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Annual cashflow statement for Inotiv, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.79-4.6810.9-337-105
Depreciation
Deferred Taxes
Non-Cash Items-0.0580.953-16.134186.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0920.9489.64-40.317
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities1.781.2910.7-5.2227.9
Capital Expenditures-6.88-6.2-12.5-36.3-27.5
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.27-3.93-41.6-297-1.25
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-8.15-10.1-54.1-334-28.8
Financing Cash Flow Items-0.094-0.127-6.22-11.2-0.077
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6.219.6419920315.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.1670.8156-13816.5